# A Study of KC1086 in Patients With Advanced Solid Tumors

> **NCT07118709** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Konruns Pharmaceutical Co., Ltd.** · enrollment: 66 (estimated)

## Conditions studied

- Advanced Solid Tumors Cancer

## Interventions

- **DRUG:** KC1086

## Key facts

- **NCT ID:** NCT07118709
- **Lead sponsor:** Beijing Konruns Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2028-08
- **Final completion:** 2028-12
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07118709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07118709, "A Study of KC1086 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07118709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*